Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Impact of Veliparib, Paclitaxel Dosing Regimen, and Germline BRCA Status on the Primary Treatment of Serous Ovarian Cancer – an Ancillary Data Analysis of the VELIA Trial

Carol Aghajanian,Elizabeth M. Swisher,Aikou Okamoto,Karina Dahl Steffensen,Michael A. Bookman,Gini F. Fleming,Michael Friedlander,Kathleen N. Moore,Krishnansu S. Tewari,David M. O'Malley,John K. Chan,Christine Ratajczak,Hideyuki Hashiba,Meijing Wu,Minh H. Dinh,Robert L. Coleman

Gynecologic Oncology（2021）

Cited 8|Views41
Key words
Veliparib,Ovarian cancer,PARP inhibitor,Dose-dense paclitaxel,g BRCA,Homologous recombination de ficiency
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined